HIV 1 News and Research

RSS

MV vaccine prevents TB in people with HIV infection

Results from clinical trials conducted in Tanzania show that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection. Findings from the trials, which were conducted by investigators from Dartmouth Medical School in the United States, will be published in the next issue of AIDS, the leading journal in the field of HIV and AIDS research. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

3 Feb 2010

Artefill could be viable for lipoatrophy and non-surgical anti-aging enhancement

Suneva Medical, a privately-held aesthetic medical device company, today announced that two clinical studies suggest Artefill may be a safe, effective, long-term treatment option for age-related and HIV lipoatrophy patients.

3 Feb 2010

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that sales of its recently launched over-the-counter pain reliever, Cobroxin, totaled $583,955 for the fourth quarter ending December 31, 2009.

3 Feb 2010

Obama's FY 2011 budget gives global health funding boost

President Barack Obama's FY 2011 budget request for global health totals $9.6 billion and includes funding for global health activities within the State Department, USAID and HHS, the Wall Street Journal reports

3 Feb 2010

HHS appoints new members to Presidential Advisory Council on HIV/AIDS

Health and Human Services Secretary Kathleen Sebelius announced today the appointment of 24 new members to the Presidential Advisory Council on HIV/AIDS (PACHA). The PACHA’s chair, Dr. Helene Gayle, was appointed in August 2009.

2 Feb 2010

Global AIDS Alliance calls for Congress to fully fund the Global Health Initiative

President Obama's budget, transmitted to Congress this morning, includes $8.5 billion for a Global Health Initiative. Based on projections to continue supporting robust U.S. programs to fight AIDS, TB and malaria and implement GHI priorities -- $16.4 billion is required in FY2011.

2 Feb 2010

Overview of newly evolving technologies for diagnosing and monitoring HIV infections

Rising consumer awareness that early diagnosis and treatment can delay the progression of human immunodeficiency virus (HIV) to anti-immuno deficiency syndrome (AIDS) has had a telling impact on the sales of HIV tests.

2 Feb 2010

Also in Global Health News: Retrovirus enzyme; audit of USAID program; Africa's agriculture

A study published on Sunday in the journal Nature has shed light on the enzyme integrase, "which is found in retroviruses like HIV and is a target for some of the newest HIV medicines," Reuters reports. Scientists at the Imperial College London and Harvard University grew a crystal of integrase in the lab allowing them to see the enzyme's structure. According to the news service, the scientists "said that having the integrase structure means researchers can begin fully to understand how integrase inhibitor drugs work, how they might be improved, and how to stop HIV developing resistance to them," according to the news service (Kelland, 2/1).

2 Feb 2010

Study shows antiviral drugs could offer protection against HIV, Ebola, herpes and hepatitis C

The development of antibiotics gave physicians seemingly miraculous weapons against infectious disease. Effective cures for terrible afflictions like pneumonia, syphilis and tuberculosis were suddenly at hand. Moreover, many of the drugs that made them possible were versatile enough to knock out a wide range of deadly bacterial threats.

2 Feb 2010

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

"We are delighted to be working with such esteemed institutions in order to generate cutting-edge therapeutic antibodies," said Matthew Baker, chief scientific officer and co-founder of Antitope. "This agreement combines our partners' expertise in novel therapeutic strategies with Antitope's expertise in engineering humanized antibodies to create therapeutic antibodies that may have a significant impact on the treatment of these major diseases."

2 Feb 2010

Obama's budget to boost Medicaid funding, broaden global health approach

President Obama's budget proposal tops $3.8 trillion, and would draw a $1.3 trillion shortfall in 2011 despite efforts to freeze and cut spending and channel an extra $100 billion to immediately attack the high unemployment rate, The Washington Post reports.

2 Feb 2010

Serious liver disorder associated with use of HIV drug, FDA warns

The U.S. Food and Drug Administration today announced that non-cirrhotic portal hypertension, a rare, but serious, liver disorder, has been reported in some HIV patients taking Videx/Videx EC (didanosine).

2 Feb 2010

Researchers identify antiviral small molecule that is effective against numerous viruses

Viruses are insidious creatures. They differ from each other in many ways, and they can mutate - at times seemingly at will, as with HIV - to resist a host of weapons fired at them. Complicating matters further is that new viruses are constantly emerging.

2 Feb 2010

More details on Obama's global health strategy expected along with budget release, Wall Street Journal reports

"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports.

2 Feb 2010

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

An experimental vaccine was found to reduce the rate of tuberculosis infections in patients living with HIV, "the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations," Bloomberg reports (Bennett, 1/29). Tuberculosis accounts for up to one-third of AIDS deaths worldwide, CBC News reports.

1 Feb 2010

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia® (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain.

1 Feb 2010

Breakthrough in HIV research leads to better treatment potential

Researchers have made a breakthrough in HIV research that had eluded scientists for over 20 years, potentially leading to better treatments for HIV, in a study published today in the journal Nature.

31 Jan 2010

Artists and social agencies collaborate to deliver services for needy people

Black history will be made on Thursday, February 4th at Arthur Bennett Hall in Brooklyn with the opening of "Artists Speaking for the Spirits," an exhibition of mural-sized paintings by 40 artists of African ancestry.

30 Jan 2010

New vaccine effective in preventing TB in HIV patients

Investigators from Dartmouth Medical School (DMS) have reported results of a clinical trial showing that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection.

30 Jan 2010

Recent releases in Global Health

Rajiv Shah's appointment as USAID administrator "comes at a crucial time of challenge and opportunity for the Agency to improve the nutritional well-being of impoverished societies," write the authors of a Lancet Comment that examines the U.S. Global Hunger and Food Security Initiative. Though the initiative "sends a clear message to the world about U.S. intent to partner with poor nations to achieve their national food and nutrition goals … the Initiative's nutrition plan, unlike its detailed agricultural blueprint, currently lacks a comprehensive set of aims, activities, research needs, and programme benchmarks," the authors write.

29 Jan 2010

HIV 1 News and Research

MV vaccine prevents TB in people with HIV infection

Artefill could be viable for lipoatrophy and non-surgical anti-aging enhancement

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Obama's FY 2011 budget gives global health funding boost

HHS appoints new members to Presidential Advisory Council on HIV/AIDS

Global AIDS Alliance calls for Congress to fully fund the Global Health Initiative

Overview of newly evolving technologies for diagnosing and monitoring HIV infections

Also in Global Health News: Retrovirus enzyme; audit of USAID program; Africa's agriculture

Study shows antiviral drugs could offer protection against HIV, Ebola, herpes and hepatitis C

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

Obama's budget to boost Medicaid funding, broaden global health approach

Serious liver disorder associated with use of HIV drug, FDA warns

Researchers identify antiviral small molecule that is effective against numerous viruses

More details on Obama's global health strategy expected along with budget release, Wall Street Journal reports

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Breakthrough in HIV research leads to better treatment potential

Artists and social agencies collaborate to deliver services for needy people

New vaccine effective in preventing TB in HIV patients

Recent releases in Global Health

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News